There have been 50 recent insider transactions recorded for National Health Investors, Inc. (NHI), including 20 buys and 26 sells. Total insider buying was valued at $9.07M and total insider selling at $19.93M.
Notable insiders with recent activity include Blankenship Elizabeth Jackson, Mccabe Robert A Jr, Colden Tracy M J. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NHI
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2027-03-03 |
Blankenship Elizabeth Jackson |
SVP, Legal Affairs |
Unknown |
8,334 |
$73.34 |
$611.22K |
- |
| 2026-03-03 |
Mccabe Robert A Jr |
Director |
RSU Award |
1,268 |
- |
- |
43,269 |
| 2026-03-03 |
Colden Tracy M J |
Director |
RSU Award |
1,268 |
- |
- |
12,858 |
| 2026-03-03 |
Jobe James R |
Director |
RSU Award |
1,268 |
- |
- |
1,268 |
| 2026-03-03 |
Mendelsohn D. Eric |
CEO and President |
Tax Withholding of RSU |
597 |
$86.75 |
$51.79K |
132,210 |
| 2026-03-03 |
Pascoe Kevin Carlton |
Chief Investment Officer |
RSU Award |
5,072 |
- |
- |
73,428 |
| 2026-03-03 |
Spaid John L |
CFO/evp Finance |
Option Exercise (Sell) |
15,000 |
$73.34 |
$1.1M |
- |
| 2026-03-03 |
Travis David L |
SVP/chief Accounting Officer |
Tax Withholding of RSU |
411 |
$86.75 |
$35.65K |
40,847 |
| 2026-03-03 |
Chapin Robert |
Director |
RSU Award |
1,268 |
- |
- |
1,268 |
| 2026-03-03 |
Todd Candice W |
Director |
RSU Award |
1,268 |
- |
- |
2,563 |
| 2026-03-03 |
Donohue Lilly |
Director |
RSU Award |
1,268 |
- |
- |
1,268 |
| 2026-03-03 |
Blankenship Elizabeth Jackson |
SVP, Legal Affairs |
RSU Award |
2,420 |
- |
- |
2,420 |
| 2026-03-03 |
Pascoe Kevin Carlton |
Chief Investment Officer |
RSU Award |
4,726 |
- |
- |
73,082 |
| 2026-03-03 |
Spaid John L |
CFO/evp Finance |
RSU Award |
5,072 |
- |
- |
56,601 |
| 2026-02-23 |
Mendelsohn D. Eric |
CEO and President |
Option Exercise (Sell) |
13,334 |
$57.76 |
$770.17K |
- |
| 2026-02-23 |
Pascoe Kevin Carlton |
Chief Investment Officer |
Option Exercise (Sell) |
8,500 |
$57.76 |
$490.96K |
- |
| 2026-02-23 |
Spaid John L |
CFO/evp Finance |
Option Exercise (Sell) |
8,500 |
$57.76 |
$490.96K |
- |
| 2026-02-23 |
Travis David L |
SVP/chief Accounting Officer |
Option Exercise (Sell) |
8,334 |
$57.76 |
$481.37K |
- |
| 2026-02-19 |
Colden Tracy M J |
Director |
Option Exercise (Sell) |
10,000 |
$73.34 |
$733.4K |
- |
| 2026-02-17 |
Jobe James R |
Director |
Option Exercise (Sell) |
10,000 |
$73.34 |
$733.4K |
- |
| 2026-02-17 |
Mendelsohn D. Eric |
CEO and President |
Option Exercise (Sell) |
25,000 |
$73.34 |
$1.83M |
- |
| 2026-02-17 |
Donohue Lilly |
Director |
Unknown |
- |
- |
- |
- |
| 2026-02-17 |
Blankenship Elizabeth Jackson |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-02-12 |
Mccabe Robert A Jr |
Director |
Option Exercise (Sell) |
10,000 |
$73.34 |
$733.4K |
- |
| 2026-02-11 |
Pascoe Kevin Carlton |
Chief Investment Officer |
Option Exercise (Sell) |
15,000 |
$73.34 |
$1.1M |
- |
| 2026-02-09 |
Travis David L |
SVP/chief Accounting Officer |
Option Exercise (Sell) |
8,334 |
$54.73 |
$456.12K |
- |
| 2026-02-05 |
Todd Candice W |
Director |
Option Exercise (Sell) |
10,000 |
$73.34 |
$733.4K |
- |
| 2026-02-01 |
Gaines Kristin Sallee |
SVP/chief Transaction Officer |
Option Exercise (Sell) |
18,334 |
$53.41 |
$979.22K |
- |
| 2026-01-30 |
Pascoe Kevin Carlton |
Chief Investment Officer |
Option Exercise (Sell) |
8,500 |
$54.73 |
$465.21K |
- |
| 2026-01-27 |
Adams Robert G |
Director |
Option Exercise (Sell) |
10,000 |
$73.34 |
$733.4K |
- |
| 2026-01-16 |
Spaid John L |
CFO/evp Finance |
Option Exercise (Sell) |
15,000 |
$73.34 |
$1.1M |
- |
| 2026-01-15 |
Mendelsohn D. Eric |
CEO and President |
Option Exercise (Sell) |
13,334 |
$54.73 |
$729.77K |
- |
| 2026-01-14 |
Mccabe Robert A Jr |
Director |
Option Exercise (Sell) |
25,000 |
$69.20 |
$1.73M |
- |
| 2025-12-09 |
Swafford Charlotte A |
Director |
Option Exercise (Sell) |
25,000 |
$53.41 |
$1.34M |
- |
| 2025-11-20 |
Jobe James R |
Director |
Option Exercise (Sell) |
25,000 |
$69.20 |
$1.73M |
- |
| 2025-09-23 |
Travis David L |
SVP/chief Accounting Officer |
Option Exercise (Sell) |
11,334 |
$69.20 |
$784.31K |
- |
| 2025-05-08 |
Chapin Robert |
Director |
RSU Award |
10,000 |
$75.87 |
$758.7K |
10,000 |
| 2025-05-05 |
Mendelsohn D. Eric |
CEO and President |
Tax Withholding of RSU |
394 |
$76.04 |
$29.96K |
96,133 |
| 2025-05-05 |
Spaid John L |
CFO/evp Finance |
Tax Withholding of RSU |
259 |
$76.04 |
$19.69K |
44,424 |
| 2025-03-28 |
Adams Robert G |
Director |
Option Exercise (Sell) |
10,000 |
$54.73 |
$547.3K |
- |
| 2025-03-26 |
Chapin Robert |
Director |
Unknown |
- |
- |
- |
- |
| 2025-03-03 |
Adams Robert G |
Director |
RSU Award |
10,000 |
$73.34 |
$733.4K |
10,000 |
| 2025-03-03 |
Swafford Charlotte A |
Director |
RSU Award |
10,000 |
$73.34 |
$733.4K |
10,000 |
| 2025-03-03 |
Mccabe Robert A Jr |
Director |
RSU Award |
10,000 |
$73.34 |
$733.4K |
10,000 |
| 2025-03-03 |
Colden Tracy M J |
Director |
RSU Award |
10,000 |
$73.34 |
$733.4K |
10,000 |
| 2025-03-03 |
Jobe James R |
Director |
RSU Award |
10,000 |
$73.34 |
$733.4K |
10,000 |
| 2025-03-03 |
Mendelsohn D. Eric |
CEO and President |
RSU Award |
25,000 |
$73.34 |
$1.83M |
25,000 |
| 2025-03-03 |
Gaines Kristin Sallee |
SVP/chief Transaction Officer |
RSU Award |
8,333 |
$73.34 |
$611.14K |
8,333 |
| 2025-03-03 |
Pascoe Kevin Carlton |
Chief Investment Officer |
RSU Award |
15,000 |
$73.34 |
$1.1M |
15,000 |
| 2025-03-03 |
Spaid John L |
CFO/evp Finance |
RSU Award |
15,000 |
$73.34 |
$1.1M |
15,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
